Adipose Tissue, at the Core of the Action of Incretin and Glucagon-Based Anti-Obesity Drugs por Walter Suárez Carmona | Sep 16, 2025
Managing Adverse Effects of Incretin-Based Medications for Obesity por Walter Suárez Carmona | Sep 3, 2025
Modulation of metabolic, inflammatory and fibrotic pathways by semaglutide in metabolic dysfunction-associated steatohepatitis por Walter Suárez Carmona | Sep 2, 2025
